Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). The...
MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC)...
New research has argued that GPs in the UK are lacking the skills needed to adequately handle chronic opioid use in their patients, and the...
The number of Americans infected with Hepatitis A has increased 300% in the past three years, according to figures from the CDC.
Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years.
Eli Lilly's Cyramza has received approval in the US as a single agent for the treatment of hepatocellular carcinoma, the FDA has confirmed.
Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms fixed prices...
The FDA has revealed that it plans to terminate its "alternative summary reporting" programme which has allowed the manufacturers of medical...
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine as Lundbeck acquire Abide Therapeutics in deal worth $400 million....
NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the NHS in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches